Skip to main content
Erschienen in: Inflammation 4/2023

12.05.2023 | RESEARCH

Performance of Machine Learning Algorithms for Predicting Disease Activity in Inflammatory Bowel Disease

verfasst von: Weimin Cai, Jun Xu, Yihan Chen, Xiao Wu, Yuan Zeng, Fujun Yu

Erschienen in: Inflammation | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to explore the effectiveness of predicting disease activity in patients with inflammatory bowel disease (IBD), using machine learning (ML) models. A retrospective research was undertaken on IBD patients who were admitted into the First Affiliated Hospital of Wenzhou Medical University between September 2011 and September 2019. At first, data were randomly split into a 3:1 ratio of training to test set. The least absolute shrinkage and selection operator (LASSO) algorithm was applied to reduce the dimension of variables. These variables were used to generate seven ML algorithms, namely random forests (RFs), adaptive boosting (AdaBoost), K-nearest neighbors (KNNs), support vector machines (SVMs), naïve Bayes (NB), ridge regression, and eXtreme gradient boosting (XGBoost) to train to predict disease activity in IBD patients. SHapley Additive exPlanation (SHAP) analysis was performed to rank variable importance. A total of 876 participants with IBD, consisting of 275 ulcerative colitis (UC) and 601 Crohn’s disease (CD), were retrospectively enrolled in the study. Thirty-three variables were obtained from the clinical characteristics and laboratory tests of the participants. Finally, after LASSO analysis, 11 and 5 variables were screened out to construct ML models for CD and UC, respectively. All seven ML models performed well in predicting disease activity in the CD and UC test sets. Among these ML models, SVM was more effective in predicting disease activity in the CD group, whose AUC reached 0.975, sensitivity 0.947, specificity 0.920, and accuracy 0.933. AdaBoost performed best for the UC group, with an AUC of 0.911, sensitivity 0.844, specificity 0.875, and accuracy 0.855. ML algorithms were available and capable of predicting disease activity in IBD patients. Based on clinical and laboratory variables, ML algorithms demonstrate great promise in guiding physicians’ decision-making.
Literatur
1.
Zurück zum Zitat Molodecky, N.A., I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, G. Chernoff, E.I. Benchimol, R. Panaccione, S. Ghosh, H.W. Barkema, et al. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (1): 46–54.e42; quiz e30.PubMedCrossRef Molodecky, N.A., I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, G. Chernoff, E.I. Benchimol, R. Panaccione, S. Ghosh, H.W. Barkema, et al. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (1): 46–54.e42; quiz e30.PubMedCrossRef
2.
Zurück zum Zitat Ng, S.C., H.Y. Shi, N. Hamidi, F.E. Underwood, W. Tang, E.I. Benchimol, R. Panaccione, S. Ghosh, J.C.Y. Wu, F.K.L. Chan, et al. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390 (10114): 2769–2778.PubMedCrossRef Ng, S.C., H.Y. Shi, N. Hamidi, F.E. Underwood, W. Tang, E.I. Benchimol, R. Panaccione, S. Ghosh, J.C.Y. Wu, F.K.L. Chan, et al. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390 (10114): 2769–2778.PubMedCrossRef
3.
Zurück zum Zitat Sartor, R.B. 2006. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology 3 (7): 390–407.CrossRef Sartor, R.B. 2006. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology 3 (7): 390–407.CrossRef
4.
Zurück zum Zitat Xavier, R.J., and D.K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (7152): 427–434.PubMedCrossRef Xavier, R.J., and D.K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (7152): 427–434.PubMedCrossRef
5.
Zurück zum Zitat Byron, C., N. Cornally, A. Burton, and E. Savage. 2020. Challenges of living with and managing inflammatory bowel disease: a meta-synthesis of patients’ experiences. Journal of Clinical Nursing 29 (3–4): 305–319.PubMedCrossRef Byron, C., N. Cornally, A. Burton, and E. Savage. 2020. Challenges of living with and managing inflammatory bowel disease: a meta-synthesis of patients’ experiences. Journal of Clinical Nursing 29 (3–4): 305–319.PubMedCrossRef
6.
Zurück zum Zitat Nahon, S., P. Lahmek, B. Lesgourgues, C. Poupardin, S. Chaussade, L. Peyrin-Biroulet, and V. Abitbol. 2014. Diagnostic delay in a French cohort of Crohn’s disease patients. Journal of Crohn’s & Colitis 8 (9): 964–969.CrossRef Nahon, S., P. Lahmek, B. Lesgourgues, C. Poupardin, S. Chaussade, L. Peyrin-Biroulet, and V. Abitbol. 2014. Diagnostic delay in a French cohort of Crohn’s disease patients. Journal of Crohn’s & Colitis 8 (9): 964–969.CrossRef
7.
Zurück zum Zitat Dulai, P.S., L. Peyrin-Biroulet, S. Danese, B.E. Sands, A. Dignass, D. Turner, G. Mantzaris, J. Schölmerich, J.Y. Mary, W. Reinisch, et al. 2019. Approaches to integrating biomarkers into clinical trials and care pathways as targets for the treatment of inflammatory bowel diseases. Gastroenterology 157 (4): 1032-1043.e1031.PubMedCrossRef Dulai, P.S., L. Peyrin-Biroulet, S. Danese, B.E. Sands, A. Dignass, D. Turner, G. Mantzaris, J. Schölmerich, J.Y. Mary, W. Reinisch, et al. 2019. Approaches to integrating biomarkers into clinical trials and care pathways as targets for the treatment of inflammatory bowel diseases. Gastroenterology 157 (4): 1032-1043.e1031.PubMedCrossRef
8.
Zurück zum Zitat Bromke, M.A., K. Neubauer, R. Kempiński, and M. Krzystek-Korpacka. 2021. Faecal calprotectin in assessment of mucosal healing in adults with inflammatory bowel disease: a meta-analysis. Journal of Clinical Medicine 10 (10): 2203.PubMedPubMedCentralCrossRef Bromke, M.A., K. Neubauer, R. Kempiński, and M. Krzystek-Korpacka. 2021. Faecal calprotectin in assessment of mucosal healing in adults with inflammatory bowel disease: a meta-analysis. Journal of Clinical Medicine 10 (10): 2203.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Buisson, A., F. Gonzalez, F. Poullenot, S. Nancey, E. Sollellis, M. Fumery, B. Pariente, M. Flamant, C. Trang-Poisson, G. Bonnaud, et al. 2017. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflammatory Bowel Diseases 23 (8): 1425–1433.PubMedCrossRef Buisson, A., F. Gonzalez, F. Poullenot, S. Nancey, E. Sollellis, M. Fumery, B. Pariente, M. Flamant, C. Trang-Poisson, G. Bonnaud, et al. 2017. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflammatory Bowel Diseases 23 (8): 1425–1433.PubMedCrossRef
10.
Zurück zum Zitat Li, R., A. Shinde, A. Liu, S. Glaser, Y. Lyou, B. Yuh, J. Wong, and A. Amini. 2020. Machine learning-based interpretation and visualization of nonlinear interactions in prostate cancer survival. JCO Clinical Cancer Informatics 4: 637–646.PubMedCrossRef Li, R., A. Shinde, A. Liu, S. Glaser, Y. Lyou, B. Yuh, J. Wong, and A. Amini. 2020. Machine learning-based interpretation and visualization of nonlinear interactions in prostate cancer survival. JCO Clinical Cancer Informatics 4: 637–646.PubMedCrossRef
11.
Zurück zum Zitat Obermeyer, Z., and E.J. Emanuel. 2016. Predicting the future - big data, machine learning, and clinical medicine. New England Journal of Medicine 375 (13): 1216–1219.PubMedCrossRef Obermeyer, Z., and E.J. Emanuel. 2016. Predicting the future - big data, machine learning, and clinical medicine. New England Journal of Medicine 375 (13): 1216–1219.PubMedCrossRef
12.
Zurück zum Zitat Woodman, R.J., K. Bryant, M.J. Sorich, A. Pilotto, and A.A. Mangoni. 2021. Use of multiprognostic index domain scores, clinical data, and machine learning to improve 12-month mortality risk prediction in older hospitalized patients: prospective cohort study. Journal of Medical Internet Research 23 (6): e26139.PubMedPubMedCentralCrossRef Woodman, R.J., K. Bryant, M.J. Sorich, A. Pilotto, and A.A. Mangoni. 2021. Use of multiprognostic index domain scores, clinical data, and machine learning to improve 12-month mortality risk prediction in older hospitalized patients: prospective cohort study. Journal of Medical Internet Research 23 (6): e26139.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Van Calster, B., and L. Wynants. 2019. Machine learning in medicine. New England Journal of Medicine 380 (26): 2588.PubMedCrossRef Van Calster, B., and L. Wynants. 2019. Machine learning in medicine. New England Journal of Medicine 380 (26): 2588.PubMedCrossRef
14.
Zurück zum Zitat Choi, R.Y., A.S. Coyner, J. Kalpathy-Cramer, M.F. Chiang, and J.P. Campbell. 2020. Introduction to machine learning, neural networks, and deep learning. Translational Vision Science & Technology 9 (2): 14. Choi, R.Y., A.S. Coyner, J. Kalpathy-Cramer, M.F. Chiang, and J.P. Campbell. 2020. Introduction to machine learning, neural networks, and deep learning. Translational Vision Science & Technology 9 (2): 14.
15.
Zurück zum Zitat Banerjee, A., S. Ray, B. Vorselaars, J. Kitson, M. Mamalakis, S. Weeks, M. Baker, and L.S. Mackenzie. 2020. Use of machine learning and artificial intelligence to predict SARS-CoV-2 infection from full blood counts in a population. International Immunopharmacology 86: 106705.PubMedPubMedCentralCrossRef Banerjee, A., S. Ray, B. Vorselaars, J. Kitson, M. Mamalakis, S. Weeks, M. Baker, and L.S. Mackenzie. 2020. Use of machine learning and artificial intelligence to predict SARS-CoV-2 infection from full blood counts in a population. International Immunopharmacology 86: 106705.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Zhou, Z., Z. Xiong, R. Cheng, Q. Luo, Y. Li, Q. Xie, P. Xiao, D. Hu, X. Hu, Y. Shen, et al. 2023. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease. European Radiology 33 (3): 1862–1872.PubMedCrossRef Zhou, Z., Z. Xiong, R. Cheng, Q. Luo, Y. Li, Q. Xie, P. Xiao, D. Hu, X. Hu, Y. Shen, et al. 2023. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease. European Radiology 33 (3): 1862–1872.PubMedCrossRef
17.
Zurück zum Zitat Manandhar, I., A. Alimadadi, S. Aryal, P.B. Munroe, B. Joe, and X. Cheng. 2021. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases. American Journal of Physiology Gastrointestinal and Liver Physiology 320 (3): G328-g337.PubMedPubMedCentralCrossRef Manandhar, I., A. Alimadadi, S. Aryal, P.B. Munroe, B. Joe, and X. Cheng. 2021. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases. American Journal of Physiology Gastrointestinal and Liver Physiology 320 (3): G328-g337.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Jain, S., S. Kedia, T. Sethi, S. Bopanna, D.P. Yadav, S. Goyal, R. Padhan, P.M. Venigalla, P. Sahni, N.R. Dash, et al. 2018. Predictors of long-term outcomes in patients with acute severe colitis: a northern Indian cohort study. Journal of Gastroenterology and Hepatology 33 (3): 615–622.PubMedCrossRef Jain, S., S. Kedia, T. Sethi, S. Bopanna, D.P. Yadav, S. Goyal, R. Padhan, P.M. Venigalla, P. Sahni, N.R. Dash, et al. 2018. Predictors of long-term outcomes in patients with acute severe colitis: a northern Indian cohort study. Journal of Gastroenterology and Hepatology 33 (3): 615–622.PubMedCrossRef
19.
Zurück zum Zitat Torres, J., F. Caprioli, K.H. Katsanos, T. Lobatón, D. Micic, M. Zerôncio, G. Van Assche, J.C. Lee, J.O. Lindsay, D.T. Rubin, et al. 2016. Predicting outcomes to optimize disease management in inflammatory bowel diseases. Journal of Crohn’s & Colitis 10 (12): 1385–1394.CrossRef Torres, J., F. Caprioli, K.H. Katsanos, T. Lobatón, D. Micic, M. Zerôncio, G. Van Assche, J.C. Lee, J.O. Lindsay, D.T. Rubin, et al. 2016. Predicting outcomes to optimize disease management in inflammatory bowel diseases. Journal of Crohn’s & Colitis 10 (12): 1385–1394.CrossRef
20.
Zurück zum Zitat Kugathasan, S., L.A. Denson, T.D. Walters, M.O. Kim, U.M. Marigorta, M. Schirmer, K. Mondal, C. Liu, A. Griffiths, J.D. Noe, et al. 2017. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389 (10080): 1710–1718.PubMedPubMedCentralCrossRef Kugathasan, S., L.A. Denson, T.D. Walters, M.O. Kim, U.M. Marigorta, M. Schirmer, K. Mondal, C. Liu, A. Griffiths, J.D. Noe, et al. 2017. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389 (10080): 1710–1718.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Lundberg, S.M., G. Erion, H. Chen, A. DeGrave, J.M. Prutkin, B. Nair, R. Katz, J. Himmelfarb, N. Bansal, and S.I. Lee. 2020. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell 2 (1): 56–67.PubMedPubMedCentralCrossRef Lundberg, S.M., G. Erion, H. Chen, A. DeGrave, J.M. Prutkin, B. Nair, R. Katz, J. Himmelfarb, N. Bansal, and S.I. Lee. 2020. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell 2 (1): 56–67.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Thorsen-Meyer, H.C., D. Placido, B.S. Kaas-Hansen, A.P. Nielsen, T. Lange, A.B. Nielsen, P. Toft, J. Schierbeck, T. Strøm, P.J. Chmura, et al. 2022. Discrete-time survival analysis in the critically ill: a deep learning approach using heterogeneous data. NPJ Digit Med 5 (1): 142.PubMedPubMedCentralCrossRef Thorsen-Meyer, H.C., D. Placido, B.S. Kaas-Hansen, A.P. Nielsen, T. Lange, A.B. Nielsen, P. Toft, J. Schierbeck, T. Strøm, P.J. Chmura, et al. 2022. Discrete-time survival analysis in the critically ill: a deep learning approach using heterogeneous data. NPJ Digit Med 5 (1): 142.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Zheng, W., L. Gao, Y. Fan, C. Wang, Y. Liu, F. Tian, M. Yi, X. Peng, and C. Liu. 2023. Identification of risk factors for attempted suicide by self-poisoning and a nomogram to predict self-poisoning suicide. Frontiers in Public Health 11: 1106454.PubMedPubMedCentralCrossRef Zheng, W., L. Gao, Y. Fan, C. Wang, Y. Liu, F. Tian, M. Yi, X. Peng, and C. Liu. 2023. Identification of risk factors for attempted suicide by self-poisoning and a nomogram to predict self-poisoning suicide. Frontiers in Public Health 11: 1106454.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Li, X., L. Yan, X. Wang, C. Ouyang, C. Wang, J. Chao, J. Zhang, and G. Lian. 2022. Predictive models for endoscopic disease activity in patients with ulcerative colitis: practical machine learning-based modeling and interpretation. Front Med (Lausanne) 9: 1043412.PubMedCrossRef Li, X., L. Yan, X. Wang, C. Ouyang, C. Wang, J. Chao, J. Zhang, and G. Lian. 2022. Predictive models for endoscopic disease activity in patients with ulcerative colitis: practical machine learning-based modeling and interpretation. Front Med (Lausanne) 9: 1043412.PubMedCrossRef
25.
Zurück zum Zitat Weng, F., Y. Meng, F. Lu, Y. Wang, W. Wang, L. Xu, D. Cheng, and J. Zhu. 2022. Differentiation of intestinal tuberculosis and Crohn’s disease through an explainable machine learning method. Science and Reports 12 (1): 1714.CrossRef Weng, F., Y. Meng, F. Lu, Y. Wang, W. Wang, L. Xu, D. Cheng, and J. Zhu. 2022. Differentiation of intestinal tuberculosis and Crohn’s disease through an explainable machine learning method. Science and Reports 12 (1): 1714.CrossRef
26.
Zurück zum Zitat Tseng, Y., S. Mo, Y. Zeng, W. Zheng, H. Song, B. Zhong, F. Luo, L. Rong, J. Liu, and Z. Luo. 2023. Machine learning model in predicting sarcopenia in Crohn’s disease based on simple clinical and anthropometric measures. International Journal of Environmental Research and Public Health 20 (1): 656.CrossRef Tseng, Y., S. Mo, Y. Zeng, W. Zheng, H. Song, B. Zhong, F. Luo, L. Rong, J. Liu, and Z. Luo. 2023. Machine learning model in predicting sarcopenia in Crohn’s disease based on simple clinical and anthropometric measures. International Journal of Environmental Research and Public Health 20 (1): 656.CrossRef
27.
Zurück zum Zitat Rath, T., R. Atreya, J. Bodenschatz, W. Uter, C.E. Geppert, F. Vitali, S. Fischer, M.J. Waldner, J.F. Colombel, A. Hartmann, et al. 2023. Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca Trial. Gastroenterology 164 (2): 241–255.PubMedCrossRef Rath, T., R. Atreya, J. Bodenschatz, W. Uter, C.E. Geppert, F. Vitali, S. Fischer, M.J. Waldner, J.F. Colombel, A. Hartmann, et al. 2023. Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca Trial. Gastroenterology 164 (2): 241–255.PubMedCrossRef
28.
Zurück zum Zitat Stafford, I.S., M.M. Gosink, E. Mossotto, S. Ennis, and M. Hauben. 2022. A systematic review of artificial intelligence and machine learning applications to inflammatory bowel disease, with practical guidelines for interpretation. Inflammatory Bowel Diseases 28 (10): 1573–1583.PubMedPubMedCentralCrossRef Stafford, I.S., M.M. Gosink, E. Mossotto, S. Ennis, and M. Hauben. 2022. A systematic review of artificial intelligence and machine learning applications to inflammatory bowel disease, with practical guidelines for interpretation. Inflammatory Bowel Diseases 28 (10): 1573–1583.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Best, W.R., J.M. Becktel, J.W. Singleton, and F. Kern Jr. 1976. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70 (3): 439–444.PubMedCrossRef Best, W.R., J.M. Becktel, J.W. Singleton, and F. Kern Jr. 1976. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70 (3): 439–444.PubMedCrossRef
30.
Zurück zum Zitat D’Haens, G., W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, E.J. Irvine, M. Lémann, P. Marteau, P. Rutgeerts, J. Schölmerich, et al. 2007. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132 (2): 763–786.PubMedCrossRef D’Haens, G., W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, E.J. Irvine, M. Lémann, P. Marteau, P. Rutgeerts, J. Schölmerich, et al. 2007. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132 (2): 763–786.PubMedCrossRef
31.
Zurück zum Zitat Schroeder, K.W., W.J. Tremaine, and D.M. Ilstrup. 1987. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. New England Journal of Medicine 317 (26): 1625–1629.PubMedCrossRef Schroeder, K.W., W.J. Tremaine, and D.M. Ilstrup. 1987. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. New England Journal of Medicine 317 (26): 1625–1629.PubMedCrossRef
32.
Zurück zum Zitat Bang, C.S., J.Y. Ahn, J.H. Kim, Y.I. Kim, I.J. Choi, and W.G. Shin. 2021. Establishing machine learning models to predict curative resection in early gastric cancer with undifferentiated histology: development and usability study. Journal of Medical Internet Research 23 (4): e25053.PubMedPubMedCentralCrossRef Bang, C.S., J.Y. Ahn, J.H. Kim, Y.I. Kim, I.J. Choi, and W.G. Shin. 2021. Establishing machine learning models to predict curative resection in early gastric cancer with undifferentiated histology: development and usability study. Journal of Medical Internet Research 23 (4): e25053.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Gubatan, J., S. Levitte, A. Patel, T. Balabanis, M.T. Wei, and S.R. Sinha. 2021. Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions. World Journal of Gastroenterology 27 (17): 1920–1935.PubMedPubMedCentralCrossRef Gubatan, J., S. Levitte, A. Patel, T. Balabanis, M.T. Wei, and S.R. Sinha. 2021. Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions. World Journal of Gastroenterology 27 (17): 1920–1935.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Kraszewski, S., W. Szczurek, J. Szymczak, M. Reguła, and K. Neubauer. 2021. Machine learning prediction model for inflammatory bowel disease based on laboratory markers. Working model in a discovery cohort study. Journal of Clinical Medicine 10 (20): 4745.PubMedPubMedCentralCrossRef Kraszewski, S., W. Szczurek, J. Szymczak, M. Reguła, and K. Neubauer. 2021. Machine learning prediction model for inflammatory bowel disease based on laboratory markers. Working model in a discovery cohort study. Journal of Clinical Medicine 10 (20): 4745.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat D’Ascenzo, F., O. De Filippo, G. Gallone, G. Mittone, M.A. Deriu, M. Iannaccone, A. Ariza-Solé, C. Liebetrau, S. Manzano-Fernández, G. Quadri, et al. 2021. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet 397 (10270): 199–207.PubMedCrossRef D’Ascenzo, F., O. De Filippo, G. Gallone, G. Mittone, M.A. Deriu, M. Iannaccone, A. Ariza-Solé, C. Liebetrau, S. Manzano-Fernández, G. Quadri, et al. 2021. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet 397 (10270): 199–207.PubMedCrossRef
36.
Zurück zum Zitat Brajer, N., B. Cozzi, M. Gao, M. Nichols, M. Revoir, S. Balu, J. Futoma, J. Bae, N. Setji, A. Hernandez, et al. 2020. Prospective and external evaluation of a machine learning model to predict in-hospital mortality of adults at time of admission. JAMA Network Open 3 (2): e1920733.PubMedCrossRef Brajer, N., B. Cozzi, M. Gao, M. Nichols, M. Revoir, S. Balu, J. Futoma, J. Bae, N. Setji, A. Hernandez, et al. 2020. Prospective and external evaluation of a machine learning model to predict in-hospital mortality of adults at time of admission. JAMA Network Open 3 (2): e1920733.PubMedCrossRef
37.
Zurück zum Zitat Ma, C., R. Battat, C.E. Parker, R. Khanna, V. Jairath, and B.G. Feagan. 2019. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? Expert Review of Gastroenterology & Hepatology 13 (4): 319–330.CrossRef Ma, C., R. Battat, C.E. Parker, R. Khanna, V. Jairath, and B.G. Feagan. 2019. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? Expert Review of Gastroenterology & Hepatology 13 (4): 319–330.CrossRef
38.
Zurück zum Zitat Chen, P., G. Zhou, J. Lin, L. Li, Z. Zeng, M. Chen, and S. Zhang. 2020. Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine 7: 123.PubMedPubMedCentralCrossRef Chen, P., G. Zhou, J. Lin, L. Li, Z. Zeng, M. Chen, and S. Zhang. 2020. Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine 7: 123.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Menees, S.B., C. Powell, J. Kurlander, A. Goel, and W.D. Chey. 2015. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. American Journal of Gastroenterology 110 (3): 444–454.PubMedCrossRef Menees, S.B., C. Powell, J. Kurlander, A. Goel, and W.D. Chey. 2015. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. American Journal of Gastroenterology 110 (3): 444–454.PubMedCrossRef
41.
Zurück zum Zitat Bambo, G.M., E. Shiferaw, and M. Melku. 2022. A mean platelet volume in inflammatory bowel disease: a systematic review and meta-analysis. PLoS ONE 17 (8): e0273417.PubMedPubMedCentralCrossRef Bambo, G.M., E. Shiferaw, and M. Melku. 2022. A mean platelet volume in inflammatory bowel disease: a systematic review and meta-analysis. PLoS ONE 17 (8): e0273417.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Krawiec, P., and E. Pac-Kożuchowska. 2020. Biomarkers and hematological indices in the diagnosis of iron deficiency in children with inflammatory bowel disease. Nutrients 12 (5): 1358.PubMedPubMedCentralCrossRef Krawiec, P., and E. Pac-Kożuchowska. 2020. Biomarkers and hematological indices in the diagnosis of iron deficiency in children with inflammatory bowel disease. Nutrients 12 (5): 1358.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Eksteen, B., E. Liaskou, and D.H. Adams. 2008. Lymphocyte homing and its role in the pathogenesis of IBD. Inflammatory Bowel Diseases 14 (9): 1298–1312.PubMedCrossRef Eksteen, B., E. Liaskou, and D.H. Adams. 2008. Lymphocyte homing and its role in the pathogenesis of IBD. Inflammatory Bowel Diseases 14 (9): 1298–1312.PubMedCrossRef
44.
Zurück zum Zitat Fu, W., H. Fu, W. Ye, Y. Han, X. Liu, S. Zhu, H. Li, R. Tang, and Q. Wang. 2021. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: a meta-analysis. International Immunopharmacology 101 (Pt B): 108235.PubMedCrossRef Fu, W., H. Fu, W. Ye, Y. Han, X. Liu, S. Zhu, H. Li, R. Tang, and Q. Wang. 2021. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: a meta-analysis. International Immunopharmacology 101 (Pt B): 108235.PubMedCrossRef
45.
Zurück zum Zitat Sappati Biyyani, R.S., B.S. Putka, and K.D. Mullen. 2010. Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease. Journal of Clinical Lipidology 4 (6): 478–482.PubMedCrossRef Sappati Biyyani, R.S., B.S. Putka, and K.D. Mullen. 2010. Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease. Journal of Clinical Lipidology 4 (6): 478–482.PubMedCrossRef
46.
Zurück zum Zitat Hashash, J.G., F. Koutroumpakis, A.M. Anderson, C.R. Rivers, M. Hosni, I.E. Koutroubakis, M. Ahsan, E. Gkiaouraki, M.A. Dunn, M. Schwartz, et al. 2022. Elevated serum globulin fraction as a biomarker of multiyear disease severity in inflammatory bowel disease. Annals of Gastroenterology 35 (6): 609–617.PubMedPubMedCentral Hashash, J.G., F. Koutroumpakis, A.M. Anderson, C.R. Rivers, M. Hosni, I.E. Koutroubakis, M. Ahsan, E. Gkiaouraki, M.A. Dunn, M. Schwartz, et al. 2022. Elevated serum globulin fraction as a biomarker of multiyear disease severity in inflammatory bowel disease. Annals of Gastroenterology 35 (6): 609–617.PubMedPubMedCentral
47.
Zurück zum Zitat Kaazan, P., Z. Tan, P. Maiyani, M. Mickenbecker, S. Edwards, C. McIvor, and J.M. Andrews. 2022. Weight and BMI patterns in a biologicals-treated IBD cohort. Digestive Diseases and Sciences 67 (12): 5628–5636.PubMedPubMedCentralCrossRef Kaazan, P., Z. Tan, P. Maiyani, M. Mickenbecker, S. Edwards, C. McIvor, and J.M. Andrews. 2022. Weight and BMI patterns in a biologicals-treated IBD cohort. Digestive Diseases and Sciences 67 (12): 5628–5636.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Lundsgaard, C., O. Hamberg, O.O. Thomsen, O.H. Nielsen, and H. Vilstrup. 1996. Increased hepatic urea synthesis in patients with active inflammatory bowel disease. Journal of Hepatology 24 (5): 587–593.PubMedCrossRef Lundsgaard, C., O. Hamberg, O.O. Thomsen, O.H. Nielsen, and H. Vilstrup. 1996. Increased hepatic urea synthesis in patients with active inflammatory bowel disease. Journal of Hepatology 24 (5): 587–593.PubMedCrossRef
49.
Zurück zum Zitat Seyed Tabib, N.S., M. Madgwick, P. Sudhakar, B. Verstockt, T. Korcsmaros, and S. Vermeire. 2020. Big data in IBD: big progress for clinical practice. Gut 69 (8): 1520–1532.PubMedCrossRef Seyed Tabib, N.S., M. Madgwick, P. Sudhakar, B. Verstockt, T. Korcsmaros, and S. Vermeire. 2020. Big data in IBD: big progress for clinical practice. Gut 69 (8): 1520–1532.PubMedCrossRef
50.
Zurück zum Zitat Javaid, A., O. Shahab, W. Adorno, P. Fernandes, E. May, and S. Syed. 2022. Machine learning predictive outcomes modeling in inflammatory bowel diseases. Inflammatory Bowel Diseases 28 (6): 819–829.PubMedCrossRef Javaid, A., O. Shahab, W. Adorno, P. Fernandes, E. May, and S. Syed. 2022. Machine learning predictive outcomes modeling in inflammatory bowel diseases. Inflammatory Bowel Diseases 28 (6): 819–829.PubMedCrossRef
51.
Zurück zum Zitat Plevy, S., M.S. Silverberg, S. Lockton, T. Stockfisch, L. Croner, J. Stachelski, M. Brown, C. Triggs, E. Chuang, F. Princen, et al. 2013. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn’s disease, and ulcerative colitis patients. Inflammatory Bowel Diseases 19 (6): 1139–1148.PubMedCrossRef Plevy, S., M.S. Silverberg, S. Lockton, T. Stockfisch, L. Croner, J. Stachelski, M. Brown, C. Triggs, E. Chuang, F. Princen, et al. 2013. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn’s disease, and ulcerative colitis patients. Inflammatory Bowel Diseases 19 (6): 1139–1148.PubMedCrossRef
52.
Zurück zum Zitat Tontini, G.E., A. Rimondi, M. Vernero, H. Neumann, M. Vecchi, C. Bezzio, and F. Cavallaro. 2021. Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons. Therapeutic Advances in Gastroenterology 14: 17562848211017730.PubMedPubMedCentralCrossRef Tontini, G.E., A. Rimondi, M. Vernero, H. Neumann, M. Vecchi, C. Bezzio, and F. Cavallaro. 2021. Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons. Therapeutic Advances in Gastroenterology 14: 17562848211017730.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Okagawa, Y., S. Abe, M. Yamada, I. Oda, and Y. Saito. 2022. Artificial Intelligence in Endoscopy. Digestive Diseases and Sciences 67 (5): 1553–1572.PubMedCrossRef Okagawa, Y., S. Abe, M. Yamada, I. Oda, and Y. Saito. 2022. Artificial Intelligence in Endoscopy. Digestive Diseases and Sciences 67 (5): 1553–1572.PubMedCrossRef
54.
Zurück zum Zitat Choi, Y.I., S.J. Park, J.W. Chung, K.O. Kim, J.H. Cho, Y.J. Kim, K.Y. Lee, K.G. Kim, D.K. Park, and Y.J. Kim. 2020. Development of machine learning model to predict the 5-year risk of starting biologic agents in patients with inflammatory bowel disease (IBD): K-CDM network study. Journal of Clinical Medicine 9 (11): 3427.PubMedPubMedCentralCrossRef Choi, Y.I., S.J. Park, J.W. Chung, K.O. Kim, J.H. Cho, Y.J. Kim, K.Y. Lee, K.G. Kim, D.K. Park, and Y.J. Kim. 2020. Development of machine learning model to predict the 5-year risk of starting biologic agents in patients with inflammatory bowel disease (IBD): K-CDM network study. Journal of Clinical Medicine 9 (11): 3427.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat McDonnell, M., R.J. Harris, F. Borca, T. Mills, L. Downey, S. Dharmasiri, M. Patel, B. Zare, M. Stammers, T.R. Smith, et al. 2020. High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. BMJ Open Gastroenterology 7 (1): e000532.PubMedPubMedCentralCrossRef McDonnell, M., R.J. Harris, F. Borca, T. Mills, L. Downey, S. Dharmasiri, M. Patel, B. Zare, M. Stammers, T.R. Smith, et al. 2020. High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. BMJ Open Gastroenterology 7 (1): e000532.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Sarrabayrouse, G., A. Elias, F. Yáñez, L. Mayorga, E. Varela, C. Bartoli, F. Casellas, N. Borruel, C. Herrera de Guise, K. Machiels, et al. 2021. Fungal and bacterial loads: noninvasive inflammatory bowel disease biomarkers for the clinical setting. mSystems 6 (2): e01277-20.PubMedPubMedCentralCrossRef Sarrabayrouse, G., A. Elias, F. Yáñez, L. Mayorga, E. Varela, C. Bartoli, F. Casellas, N. Borruel, C. Herrera de Guise, K. Machiels, et al. 2021. Fungal and bacterial loads: noninvasive inflammatory bowel disease biomarkers for the clinical setting. mSystems 6 (2): e01277-20.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Khorasani, H.M., H. Usefi, and L. Peña-Castillo. 2020. Detecting ulcerative colitis from colon samples using efficient feature selection and machine learning. Science and Reports 10 (1): 13744.CrossRef Khorasani, H.M., H. Usefi, and L. Peña-Castillo. 2020. Detecting ulcerative colitis from colon samples using efficient feature selection and machine learning. Science and Reports 10 (1): 13744.CrossRef
58.
Zurück zum Zitat Cheng, Y., J. Yang, Q. Wu, L. Cao, B. Wang, X. Jin, Y. Kang, Z. Zhang, and M. He. 2022. Machine learning for the prediction of acute kidney injury in patients with acute pancreatitis admitted to the intensive care unit. Chinese Medical Journal 135 (23): 2886–2887.PubMedCrossRef Cheng, Y., J. Yang, Q. Wu, L. Cao, B. Wang, X. Jin, Y. Kang, Z. Zhang, and M. He. 2022. Machine learning for the prediction of acute kidney injury in patients with acute pancreatitis admitted to the intensive care unit. Chinese Medical Journal 135 (23): 2886–2887.PubMedCrossRef
59.
Zurück zum Zitat Weick, K.E., and K.H. Roberts. 1993. Collective mind in organizations: heedful interrelating on flight decks. Administrative Science Quarterly 38: 357–381.CrossRef Weick, K.E., and K.H. Roberts. 1993. Collective mind in organizations: heedful interrelating on flight decks. Administrative Science Quarterly 38: 357–381.CrossRef
60.
Zurück zum Zitat Jones, B.E., J. Ying, M. Nevers, P.R. Alba, T. He, O.V. Patterson, M.M. Jones, V. Stevens, J. Shen, J. Humpherys, et al. 2021. Computerized mortality prediction for community-acquired pneumonia at 117 Veterans Affairs Medical Centers. Annals of the American Thoracic Society 18 (7): 1175–1184.PubMedCrossRef Jones, B.E., J. Ying, M. Nevers, P.R. Alba, T. He, O.V. Patterson, M.M. Jones, V. Stevens, J. Shen, J. Humpherys, et al. 2021. Computerized mortality prediction for community-acquired pneumonia at 117 Veterans Affairs Medical Centers. Annals of the American Thoracic Society 18 (7): 1175–1184.PubMedCrossRef
61.
Zurück zum Zitat Wang, Z., C. Xu, W. Liu, M. Zhang, J. Zou, M. Shao, X. Feng, Q. Yang, W. Li, X. Shi, et al. 2022. A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning. Frontiers in Endocrinology 13: 1083569.PubMedCrossRef Wang, Z., C. Xu, W. Liu, M. Zhang, J. Zou, M. Shao, X. Feng, Q. Yang, W. Li, X. Shi, et al. 2022. A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning. Frontiers in Endocrinology 13: 1083569.PubMedCrossRef
62.
Zurück zum Zitat van der Ploeg, T., P.C. Austin, and E.W. Steyerberg. 2014. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Medical Research Methodology 14: 137.PubMedPubMedCentralCrossRef van der Ploeg, T., P.C. Austin, and E.W. Steyerberg. 2014. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Medical Research Methodology 14: 137.PubMedPubMedCentralCrossRef
Metadaten
Titel
Performance of Machine Learning Algorithms for Predicting Disease Activity in Inflammatory Bowel Disease
verfasst von
Weimin Cai
Jun Xu
Yihan Chen
Xiao Wu
Yuan Zeng
Fujun Yu
Publikationsdatum
12.05.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01827-0

Weitere Artikel der Ausgabe 4/2023

Inflammation 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.